← Back to Clinical Trials
Recruiting NCT04641286

NCT04641286 Clinical Outcome Modelling of Rapid Dynamics in Acute Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04641286
Status Recruiting
Phase
Sponsor King's College Hospital NHS Trust
Condition Stroke
Study Type OBSERVATIONAL
Enrollment 8,000 participants
Start Date 2021-07-07
Primary Completion 2028-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Body motion categorisation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 8,000 participants in total. It began in 2021-07-07 with a primary completion date of 2028-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Stroke - still the second commonest cause of death and principal cause of adult neurological disability in the Western World - is characterised by rapid changes over time and marked variability in outcomes. A patient may improve or deteriorate over minutes, and the resultant disability may range from an obvious complete paralysis to subtle, task dependent incoordination of a single limb. Unlike many other neurological disorders, stroke can be exquisitely sensitive to prompt and intelligently tailored treatment, rewarding innovation in the delivery of care with real-world, tangible impact on patient outcomes. Optimal treatment therefore requires both detailed characterisation of the patient's clinical picture and its pattern of change over time. Arguably the most important aspect of the patient's clinical picture -- body movement -- remains remarkably poorly documented: quantified only subjectively and at infrequent intervals in the patient's clinical evolution. The combination of artificial intelligence with high-performance computing now enables automatic extraction of a patient's skeletal frame resolved down to major joints, like that of a stick-man, to be delivered simply, safely, and inexpensively, without the use of cumbersome body worn markers. Central to this technology is patient privacy, with the skeletal frame extracted in real time, ensuring no video data, from which patients can be identified, to be stored or transmitted by the device. Our motion categorisation system -- MoCat -- will be used to study the rapid dynamics of acute stroke, seamlessly embedded in the clinical stream. By quantifying the change in motor deficit over time we shall examine the relationship between these trajectories with clinical outcomes and develop predictive models that can support clinical management and optimise service delivery.

Eligibility Criteria

Inclusion Criteria: * Putative diagnosis of an acute stroke * Admission on the stroke unit Exclusion Criteria: * Under 18 years of age

Contact & Investigator

Central Contact

Lead Stroke Research Co-ordionator

✉ kch-tr.kingsresearch@nhs.net

📞 02032999000

Principal Investigator

Yee Mah

STUDY CHAIR

King's College Hospital NHS Trust

Frequently Asked Questions

Who can join the NCT04641286 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04641286 currently recruiting?

Yes, NCT04641286 is actively recruiting participants. Contact the research team at kch-tr.kingsresearch@nhs.net for enrollment information.

Where is the NCT04641286 trial being conducted?

This trial is being conducted at London, United Kingdom.

Who is sponsoring the NCT04641286 clinical trial?

NCT04641286 is sponsored by King's College Hospital NHS Trust. The principal investigator is Yee Mah at King's College Hospital NHS Trust. The trial plans to enroll 8,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology